Tempus AI Inc · Q2 2026 earnings

Briefing

Tempus AI Inc reported Q2 2026 results with revenue of $382.5 million, up 22% year-over-year, and swung to GAAP net income of $5.6 million.

Tempus AI Inc (TEM) delivered strong Q2 2026 results, with total revenue reaching $382.5 million, a 22% increase from the prior year, driven by 31% oncology volume growth and 36% growth in Data Licensing & Modeling. The company achieved GAAP net income of $5.6 million and Adjusted EBITDA of $8.0 million, compared to a net loss and negative EBITDA in Q2 2025. Cash and marketable securities stood at $820.7 million, and full-year 2026 revenue guidance was raised to $1.595–1.605 billion.

• Revenue grew 22% YoY to $382.5 million, with Diagnostics at $289.3 million (20% growth) and Data and Applications at $93.2 million (28% growth).
• GAAP net income turned positive at $5.6 million (EPS $0.03), versus a $42.8 million loss last year; Non-GAAP net loss per share improved to ($0.04).
• Adjusted EBITDA reached $8.0 million, a significant improvement from ($5.6 million) in Q2 2025; gross profit rose 26% to $246.5 million.
• Raised full-year 2026 revenue guidance to $1.595–1.605 billion (~25% growth) and expects ~$65 million Adjusted EBITDA; announced Personalis acquisition.

Headline financials

Revenue & EPS history

Full-year 2026 revenue guidance raised to $1.595–1.605 billion (~25% growth); expects ~$65 million Adjusted EBITDA. Guidance assumes no impact from Personalis acquisition (expected close late Q4 2026 or early 2027).